Engage the Right CDMO or CMO for Your Project

Time Saving From Months to Seconds: MAI CDMO Network enables pharma and biopharma teams to rapidly shortlist relevant CDMOs based on technical capabilities, regulatory compliance and therapeutic focus, among many other requirements. Direct Contact with Relevant Teams: Engage directly with the appropriate commercial or technical contacts, avoiding generic inboxes and accelerating meaningful discussions.

Reliable Information Manufacturer-Provided, Expert-Reviewed Data: CDMO and CMO profiles are created and maintained by the manufacturers THEMSELVES and reviewed by the MAI CDMO Network team to ensure accuracy, relevance and up-to-date technical information.

Advanced & Guided CDMO Selection Guided Search with Risk Insights: Registered users can access expert support and more detailed and unmasked information through a guided workflow that enriches search results with structured insights to help anticipate risks before engaging.

Get Started Today

Make Confident CMO / CDMO Decisions

Selecting a Contract Manufacturing Organization (CMO) or Contract Development and Manufacturing Organization (CDMO) is a strategic responsibility for pharmaceutical and biopharmaceutical teams. Professionals in CMC, External Manufacturing, Operations and Procurement must align technical feasibility, regulatory requirements, development stage, scale, timelines and long-term reliability, often under significant time pressure and across multiple stakeholders.

MAI CDMO Network is a decision-support platform designed to help teams identify, evaluate and connect with suitable CMOs and CDMOs through structured data, advanced filtering and direct access to relevant manufacturing organizations.

Accelerate Partner Identification

MAI CDMO Network enables users to rapidly shortlist relevant CDMOs based on technical capabilities, regulatory compliance, therapeutic focus, development stage and production scale, among many other requirements. What traditionally takes months can be reduced to a structured, traceable process.

Users can engage directly with the appropriate commercial or technical contacts, avoiding generic inboxes and ensuring that discussions start with the right technical and regulatory context.

High-Quality, Manufacturer-Provided Information

Accurate and current information is essential for informed manufacturing decisions. On MAI CDMO Network, CMO and CDMO profiles are created and maintained by the manufacturers themselves, ensuring that capabilities, capacities and certifications reflect operational reality.

All profiles are reviewed by the MAI CDMO Network team to ensure clarity, relevance and consistency, providing a reliable foundation for partner evaluation.

Search CDMOs by Product Type

Users can identify CDMOs with proven experience in specific product categories, including:

• Biologics: Cell and gene therapies, recombinant proteins, monoclonal antibodies and vaccines. [Search Biologics CDMOs]
• Chemical-Synthetic: Small molecule APIs, intermediates and high-potency compounds. [Search Chemical CDMOs]
• FDF / Drug Products: Solid orals, injectables, topicals and complex formulations. [Search FDF CDMOs]
• Cosmetics: Contract manufacturing for skincare and personal care products.
• Nutraceuticals / Food Supplements: Vitamins, functional foods and dietary supplements.
• Services Only: Analytics, packaging, logistics or quality-focused CDMOs.

Filter by Intended Use

Products can be matched to CDMOs based on their intended market and licensing scope:

• Human use: Prescription, OTC and hospital-use pharmaceuticals. [Search by human use]
• Veterinary use: Companion animal and livestock products. [Search veterinary CDMOs]

Each CDMO is categorized to reflect relevant authorizations and operational focus.

Match by Stage of Development

MAI CDMO Network supports selection across the full product lifecycle:

• Investigational stage: Preclinical development, clinical trial material and tech transfer (Phase I–III). [Search clinical CDMOs]
• Commercial stage: Full-scale GMP manufacturing, validation and global supply (Phase IV and post-approval). [Search commercial CDMOs]

Lifecycle management and reformulation expertise can also be identified.

Choose the Right Batch Size

Production scale is a critical decision variable. Users can filter CDMOs by:

• Small batches: Early-stage trials, personalized medicine and niche indications.
• Medium batches: Regional launches and scale-up programs.
• Large batches: Global commercial supply and long-term manufacturing.

Each CDMO profile specifies typical batch sizes and available scale-up pathways.

Target Specific Therapeutic Areas

Using ATC-based classification, MAI CDMO Network enables selection of CDMOs with experience in specific therapeutic areas, including oncology, cardiovascular, CNS, respiratory, dermatology, infectious diseases and more.

Specialized capabilities such as radiopharmaceuticals, diagnostics and nutrition-related products can also be identified.

Consider Safety & Regulatory Complexity

Users can filter CDMOs based on containment, safety and regulatory requirements, including:

• Occupational Exposure Bands (OEB 1–5) for potent and highly potent compounds
• Biological Safety Levels (BSL 1–4) for biologics and advanced therapies
• Narcotics, DEA (Schedules I–V) and other authorizations for controlled substances

This ensures alignment between product risk profile and manufacturing capabilities.

Certifications That Matter

Each CDMO is tagged with applicable certifications and market approvals, including:

• GMPs from EMA, FDA, Health Canada, PMDA, NMPA, ANVISA and other authorities
• International standards such as ISO, WHO GMP, NSF, BRCGS, ECOVADIS and Halal
• Regional approvals across more than 20 global markets

This allows rapid verification of regulatory suitability for target markets.

Discover Full-Service Capabilities

MAI CDMO Network enables users to identify CDMOs offering end-to-end or specialized services, including:

• Development services: Preformulation, tech transfer and scale-up
• Manufacturing services: GMP production of drug substances and drug products
• Analytical services: QC/QA testing, method development and validation
• Packaging & logistics: Serialization, cold chain and international distribution
• Regulatory support: Dossier preparation, CMC guidance and audits

Filters can be combined to identify full-service partners or highly specialized CDMOs.

A Practical Decision-Support Platform for Manufacturing Teams

MAI CDMO Network brings together structured manufacturer data, advanced filtering and guided selection workflows to support informed decision-making. The platform is designed to integrate naturally into the workflows of CMC, External Manufacturing and Procurement teams.

Whether evaluating new manufacturing options, building supply chain resilience or preparing future development milestones, MAI CDMO Network provides a clear and reliable starting point.

Start Exploring MAI CDMO Network

You can explore the manufacturing landscape or register to access extended information, guided selection features and direct engagement with relevant manufacturing partners.